Martin Fan

Stock Analyst at Wedbush

(0.94)
# 2324
Out of 5,441 analysts
7
Total ratings
Success rate
Average return
6 Stocks
Name Action PT Current % Upside Ratings Updated
ANAB AnaptysBio
Maintains: Outperform
40 45
19.97 125.34% 2 Aug 7, 2025
RNAC Cartesian Therapeuti...
Initiates Coverage On: Outperform
38
11 245.45% 1 Jul 9, 2025
ACRS Aclaris Therapeutics
Initiates Coverage On: Outperform
8
1.64 387.8% 1 May 28, 2025
ORKA Oruka Therapeutics
Reiterates: Outperform
40 40
n/a n/a 1 May 15, 2025
ARTV Artiva Biotherapeuti...
Reiterates: Outperform
18 18
2.55 605.88% 1 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
35
14.97 133.8% 1 Mar 20, 2025